Kinase inhibitor advances in MM: predictive biomarkers & amp; efficacy of daratumumab

Kinase inhibitors are one of the most successful forms of therapy for hematological malignancies, with further potential due to new advances. Speaking from the 1st European Myeloma Network Meeting (EM... Author: VJHemOnc Added: 07/26/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts